Journals Library

HTA - 07/03/01

Early high dose lipid-lowering therapy to avoid cardiac events

Project title: Early high dose lipid-lowering therapy to avoid cardiac events

Call to action: 07/03 Early high dose lipid-lowering therapy to avoid cardiac events

Research type: Evidence Synthesis

Chief investigator: Ms Roberta AraORCID

Lead Author: Ms Roberta AraORCID

Contractor: The University of Sheffield

Co-investigators: Mr Abdullah Pandor.

Started: January 2008 | Status: Published July 2009

Study found that rosuvastatin 40 mg/day is the most effective treatment in terms of lowering low-density lipoprotein cholesterol and is the optimal treatment for individuals with a recent history of acute coronary syndrome using a threshold of £20,000 per QALY. However, if the cost of atorvastatin decreases when the patent ends in 2011, atorvastatin 80 mg/day will become the most cost-effective treatment for all thresholds

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked


How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.